{
    "nctId": "NCT02576106",
    "briefTitle": "Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy",
    "officialTitle": "Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy",
    "overallStatus": "COMPLETED",
    "conditions": "Carcinoma, Ductal, Breast, Menopausal",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 22,
    "primaryOutcomeMeasure": "The rate of success of cryoablation procedure",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Non inflammatory unilateral and unifocal breast cancer with indication of lumpectomy\n* Menopausal women with age \\> 55 years\n* Tumor size \\<= 15 mm by ultrasonography\n* Histological confirmation (by biopsy) of invasive ductal carcinoma with SBR (Scarff-Bloom-Richardson) grade (modified by Ellis \\& Elston) 1 or 2; hormone receptors positive (Estrogen Receptor and/or Progesterone Receptor) and negative Human epidermal growth factor receptor (HER2)\n* Good lesion boundary with ultrasonography and MRI\n* Minimal distance of 5 mm between the skin and the tumor\n* Performance Status 0-1\n* Ability to understand and willingness to sign a written informed consent document\n* Covered by a medical insurance\n* Signed informed consent\n\nExclusion Criteria:\n\n* Invasive lobular carcinoma\n* Tumor with retro-nipple location\n* Extended microcalcifications (\\> 15 mm) with mammography\n* Xylocaine allergy\n* Patient deprived of freedom",
    "sex": "FEMALE",
    "minimumAge": "55 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}